BALLIET JENNIFER 4
4 · NEOGENOMICS INC · Filed Jul 7, 2021
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Award
Common Stock
2021-07-05+758→ 27,215 total - Award
Stock Option (Right to Buy)
2021-07-05$43.95/sh+4,050$177,998→ 4,050 totalExercise: $43.95Exp: 2028-07-05→ Common Stock (4,050 underlying)
Holdings
- 15,006
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (15,006 underlying) - 10,551
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (10,551 underlying) - 7,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (7,000 underlying) - 17,496
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (17,496 underlying) - 33,334
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (33,334 underlying)
Footnotes (6)
- [F1]On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vested ratably over the first three anniversaries of the grant date.
- [F2]On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F4]On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2021, Ms. Balliet was granted 10,551 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On July 5, 2021, Ms. Balliet was granted 4,050 stock options. These options vest ratably over the first four anniversary dates of the grant date.